Evrysdi™ (risdiplam) Recall
Issued March 18, 2021 · Genentech · 14,000 units affected
In March 2021, Genentech recalled the Evrysdi™ (risdiplam), a moderate health recall reported by the CPSC.
Compiled by Maya Ellison, RecallCheckr
What this means for you
The bottles containing the prescription drug can leak due to a fit issue between the press-in bottle adapter and bottleneck. If the bottle is leaking, there is a risk of drug exposure by contact with skin or eyes. Prescription drugs must be in child resistant packaging that prevents children from gaining access to the contents as required by the Poison Prevention Packaging Act (PPPA).
What you should do
- 1 Stop using Evrysdi™ (risdiplam) right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Genentech to arrange your replace. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Recall details
- Brand
- Genentech
- Category
- Health
- Recall date
- March 18, 2021
- Units affected
- 14,000
- Sold at
- Select specialty pharmacies nationwide as a prescribed medicine from August 2020 through the present. The price of the medication varies based on health insurance terms and other factors.
- Recall number
- CPSC-21729
- Made in
- Switzerland
- Issuing agency
- CPSC
In context
- Genentech has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- 14,000 units is enough to reach roughly 1 in every 9,357 US households.
- This is the 7th Health recall we've logged in 2021.